Zoetis | ZTS - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
AbbVie USD -5.94B 721M 2026-06
Align Technology USD 4.23B 83.03M 2026-06
Bayer EUR 29.71B 863M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Charles River Laboratories USD 2.84B 59.06M 2026-06
Coherus Biosciences USD 60.84M 17.78M 2026-06
Dentsply International USD 1.35B 33M 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Henry Schein USD 3.16B 109M 2026-06
Idexx Laboratories USD 1.61B 56.47M 2026-06
Illumina USD 2.84B 162M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
J&J USD 84.97B 3.78B 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Merck USD 41.93B 3.94B 2026-06
Neogen USD 2.09B 9.5M 2026-03
Pacira USD 671.98M 18.08M 2026-06
Perrigo USD 2.52B 17M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Phibro Animal Health USD 385.48M 23.65M 2026-06
Quest Diagnostics USD 7.52B 150M 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Sanofi EUR 73.14B 1.43B 2026-03
Zoetis USD 3.15B 85M 2026-06